TERF2 (Q15554) variants and mutations
TERF2 (also known as Q15554) is a human protein-coding gene encoding a telomeric repeat-binding factor 2 protein. It protects double-stranded telomeric DNA within the shelterin complex, preventing chromosome ends from activating DNA-damage responses or undergoing end-to-end fusion. Loss of function causes telomere instability, while altered telomere protection can contribute to aging and cancer biology. This analysis covers 753 TERF2 variants and mutations. Of these, 80% have computational variant effect predictions. Disease context includes neurodegenerative disease, atrial fibrillation, and lung abscess. Example TERF2 variants include A2V, A3G, and G4R.
Variant analysis overview
- Gene: TERF2
- Protein: Q15554
- UniProt accession: Q15554
- Organism: Homo sapiens
- Variants analyzed: 753
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 526 unspecified-consequence records; 119 missense variants; 8 frameshift variants; 82 synonymous variants; 4 stop-gained variants; 2 in-frame insertions; 3 splice-region variants; 1 stop retained variant; 2 stop lost; 5 in-frame deletions; 1 substitution
- Prediction scores: 604 variants have prediction scores (80% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: neurodegenerative disease, atrial fibrillation, lung abscess, bronchopneumonia, Alzheimer disease, Parkinson disease, multiple sclerosis, lysosomal storage disease, cardiovascular disorder, neoplasm, cancer, gastric cancer.
Protein structure and variant hotspots
- Protein features: 1 domains; 4 post-translational modification sites.
- Structural context: 78 variants have structural context.
- PTM context: 6 variants overlap post-translational modification sites.
- Experimental data: 54 protein positions have experimental scores. Source: TERF2 SANT/Myb domain domainome 1.0.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable TERF2 variants
Examples include A2V, A3G, G4R, A5P, A5S, A5T, G6E, G6R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2V (p.Ala2Val), gnomAD rs1406916663, CADD 23.70, PolyPhen-2 0.00
- A3G (p.Ala3Gly), gnomAD rs1414298433, CADD 23.70, PolyPhen-2 0.00
- G4R (p.Gly4Arg), cosmic curated COSV10454, TOPMed rs1446731694, gnomAD rs1446731694, CADD 23.20, PolyPhen-2 0.00
- A5P (p.Ala5Pro), TOPMed rs892268339, gnomAD rs892268339
- A5S (p.Ala5Ser), TOPMed rs892268339, gnomAD rs892268339, CADD 15.40, PolyPhen-2 0.00
- A5T (p.Ala5Thr), TOPMed rs892268339, gnomAD rs892268339, CADD 21.30, PolyPhen-2 0.00
- G6E (p.Gly6Glu), TOPMed rs936749110, gnomAD rs936749110, CADD 22.90, PolyPhen-2 0.00
- G6R (p.Gly6Arg), TOPMed rs1052487232, gnomAD rs1052487232, CADD 23.10, PolyPhen-2 0.00
- G6V (p.Gly6Val), TOPMed rs936749110, gnomAD rs936749110, CADD 22.80, PolyPhen-2 0.00
- T7K (p.Thr7Lys), TOPMed rs992001633, gnomAD rs992001633, CADD 23.00, PolyPhen-2 0.00
- T7M (p.Thr7Met), TOPMed rs992001633, gnomAD rs992001633, CADD 20.70, PolyPhen-2 0.00
- T7R (p.Thr7Arg), TOPMed rs992001633, gnomAD rs992001633, CADD 22.90, PolyPhen-2 0.00
- A8G (p.Ala8Gly), TOPMed rs958788634, gnomAD rs958788634, CADD 16.90, PolyPhen-2 0.00
- A8P (p.Ala8Pro), TOPMed rs2014191992, gnomAD rs2014191992, CADD 17.10, PolyPhen-2 0.00
- A8S (p.Ala8Ser), TOPMed rs2014191992, gnomAD rs2014191992, CADD 15.20, PolyPhen-2 0.00
- A8T (p.Ala8Thr), TOPMed rs2014191992, gnomAD rs2014191992, CADD 15.90, PolyPhen-2 0.00
- A8V (p.Ala8Val), TOPMed rs958788634, gnomAD rs958788634, CADD 13.00, PolyPhen-2 0.00
- G9C (p.Gly9Cys), TOPMed rs903878683, gnomAD rs903878683, CADD 22.80, PolyPhen-2 0.00
- G9S (p.Gly9Ser), TOPMed rs903878683, gnomAD rs903878683, CADD 22.50, PolyPhen-2 0.00
- G9V (p.Gly9Val), 1000Genomes rs772945584, ExAC rs772945584, TOPMed rs772945584, gnomAD rs772945584, CADD 22.70, PolyPhen-2 0.00
- P10H (p.Pro10His), TOPMed rs1219788477, gnomAD rs1219788477, CADD 21.20, PolyPhen-2 0.00
- P10L (p.Pro10Leu), TOPMed rs1219788477, gnomAD rs1219788477, CADD 21.80, PolyPhen-2 0.00
- P10S (p.Pro10Ser), gnomAD rs1244673970, CADD 17.40, PolyPhen-2 0.00
- A11P (p.Ala11Pro), TOPMed rs1434342134, gnomAD rs1434342134, CADD 23.80, PolyPhen-2 0.00
- A11T (p.Ala11Thr), TOPMed rs1434342134, gnomAD rs1434342134, CADD 23.70, PolyPhen-2 0.00
- S12T (p.Ser12Thr), TOPMed rs1291049941, gnomAD rs1291049941, CADD 23.70, PolyPhen-2 0.00
- G13A (p.Gly13Ala), ExAC rs771614905, TOPMed rs771614905, gnomAD rs771614905, CADD 23.50, PolyPhen-2 0.00
- P14L (p.Pro14Leu), TOPMed rs1435970131, gnomAD rs1435970131, CADD 24.40, PolyPhen-2 0.00
- P14S (p.Pro14Ser), TOPMed rs951649049, gnomAD rs951649049, CADD 19.90, PolyPhen-2 0.00
- G15C (p.Gly15Cys), TOPMed rs2014189694, CADD 24.30, PolyPhen-2 0.00
- G15D (p.Gly15Asp), gnomAD rs2014189586, CADD 22.40, PolyPhen-2 0.00
- V16A (p.Val16Ala), TOPMed rs1367134267, gnomAD rs1367134267, CADD 27.70, PolyPhen-2 0.94
- V16D (p.Val16Asp), TOPMed rs1367134267, gnomAD rs1367134267, CADD 29.50, PolyPhen-2 0.98
- V17L (p.Val17Leu), TOPMed rs2014189042, CADD 23.10, PolyPhen-2 0.90
- V17M (p.Val17Met), gnomAD 16-69357054-C-T, CADD 9.40
- R18P (p.Arg18Pro), ExAC rs761598294, gnomAD rs761598294, CADD 28.30, PolyPhen-2 0.98
- D19A (p.Asp19Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- D19G (p.Asp19Gly), ExAC rs773981277, TOPMed rs773981277, gnomAD rs773981277, CADD 29.20, PolyPhen-2 0.98
- D19H (p.Asp19His), TOPMed rs998415453, gnomAD rs998415453, CADD 26.60, PolyPhen-2 1.00
- D19N (p.Asp19Asn), TOPMed rs998415453, gnomAD rs998415453, CADD 27.50, PolyPhen-2 0.98
- D19V (p.Asp19Val), ExAC rs773981277, TOPMed rs773981277, gnomAD rs773981277, CADD 28.90, PolyPhen-2 0.99
- D19Y (p.Asp19Tyr), TOPMed rs998415453, gnomAD rs998415453, CADD 27.00, PolyPhen-2 1.00
- A21E (p.Ala21Glu), TOPMed rs1167733436, gnomAD rs1167733436, CADD 16.30, PolyPhen-2 0.17
- A21T (p.Ala21Thr), TOPMed rs2014188201, CADD 9.35, PolyPhen-2 0.00
- A21V (p.Ala21Val), cosmic curated COSV54748, TOPMed rs1167733436, gnomAD rs1167733436, CADD 14.70, PolyPhen-2 0.07
- A22P (p.Ala22Pro), TOPMed rs1463783961, gnomAD rs1463783961, CADD 27.30, PolyPhen-2 0.99
- S23* (p.Ser23Ter), gnomAD rs1392014824
- S23P (p.Ser23Pro), ExAC rs768540672, TOPMed rs768540672, gnomAD rs768540672, CADD 25.60, PolyPhen-2 0.96
- S23T (p.Ser23Thr), ExAC rs768540672, TOPMed rs768540672, gnomAD rs768540672, CADD 26.10, PolyPhen-2 0.92
- Q24R (p.Gln24Arg), Ensembl rs2014187321, CADD 25.00, PolyPhen-2 0.89
- Q24E (p.Gln24Glu), gnomAD 16-69357027-G-C, CADD 9.10
- Q24* (p.Gln24Ter), gnomAD 16-69357027-G-A, CADD 9.57
- P25L (p.Pro25Leu), ExAC rs749171225, TOPMed rs749171225, gnomAD rs749171225, CADD 24.60, PolyPhen-2 0.06
- P25Q (p.Pro25Gln), ExAC rs749171225, TOPMed rs749171225, gnomAD rs749171225, CADD 24.30, PolyPhen-2 0.14
- P25S (p.Pro25Ser), gnomAD rs1168653234, CADD 22.50, PolyPhen-2 0.00
- R26K (p.Arg26Lys), NCI-TCGA TCGA novel, CADD 22.20, PolyPhen-2 0.05, Variant assessed as somatic; moderate impact.
- R26T (p.Arg26Thr), TOPMed rs940851893, CADD 22.30, PolyPhen-2 0.07
- K27R (p.Lys27Arg), gnomAD rs1422468080, CADD 24.10, PolyPhen-2 0.95
- R28Q (p.Arg28Gln), TOPMed rs2014186450, CADD 23.10, PolyPhen-2 0.95
- R28W (p.Arg28Trp), gnomAD rs1192506837, CADD 27.90, PolyPhen-2 0.99
- P29L (p.Pro29Leu), TOPMed rs1488603906, gnomAD rs1488603906, CADD 25.30, PolyPhen-2 0.99
- R31L (p.Arg31Leu), ExAC rs779995921, TOPMed rs779995921, gnomAD rs779995921, CADD 24.50, PolyPhen-2 0.95
- R31Q (p.Arg31Gln), ExAC rs779995921, TOPMed rs779995921, gnomAD rs779995921, CADD 23.40, PolyPhen-2 0.95
- R31W (p.Arg31Trp), TOPMed rs1249784176, gnomAD rs1249784176, CADD 23.90, PolyPhen-2 0.99
- R31* (p.Arg31Ter), rs201689490, gnomAD 16-69357036-G-A, CADD 1.90
- G33C (p.Gly33Cys), TOPMed rs1482347193, gnomAD rs1482347193, CADD 27.10, PolyPhen-2 1.00
- G33S (p.Gly33Ser), TOPMed rs1482347193, gnomAD rs1482347193, CADD 26.10, PolyPhen-2 0.99
- G34R (p.Gly34Arg), TOPMed rs982962134, CADD 27.70, PolyPhen-2 1.00
- G34W (p.Gly34Trp), TOPMed rs982962134, CADD 29.10, PolyPhen-2 1.00
- E35D (p.Glu35Asp), Ensembl rs1567459023, CADD 24.20, PolyPhen-2 0.95
- G36A (p.Gly36Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G36C (p.Gly36Cys), Ensembl rs2014185120, CADD 24.80, PolyPhen-2 1.00
- A37V (p.Ala37Val), TOPMed rs1330353768, gnomAD rs1330353768, CADD 23.10, PolyPhen-2 0.00
- R38G (p.Arg38Gly), gnomAD rs1228833261, CADD 26.90, PolyPhen-2 0.95
- R38Q (p.Arg38Gln), TOPMed rs952482978, gnomAD rs952482978, CADD 25.30, PolyPhen-2 0.95
- R39G (p.Arg39Gly), TOPMed rs902821409, gnomAD rs902821409, CADD 24.20, PolyPhen-2 0.95
- R39Q (p.Arg39Gln), 1000Genomes rs549767806, ExAC rs549767806, TOPMed rs549767806, gnomAD rs549767806, CADD 25.10, PolyPhen-2 0.95
- T42A (p.Thr42Ala), gnomAD rs1451432183, CADD 13.80, PolyPhen-2 0.00
- T42M (p.Thr42Met), TOPMed rs1407822167, gnomAD rs1407822167, CADD 23.40, PolyPhen-2 0.27
- T42R (p.Thr42Arg), TOPMed rs1407822167, gnomAD rs1407822167, CADD 21.40, PolyPhen-2 0.07
- A44V (p.Ala44Val), gnomAD rs1345311616, REVEL 0.04, MetaLR 0.03
- G45R (p.Gly45Arg), gnomAD 16-69357003-C-T, CADD 8.65
- G47S (p.Gly47Ser), TOPMed rs2014182695, REVEL 0.04, MetaLR 0.04
- G48E (p.Gly48Glu), TOPMed rs1308522744, gnomAD rs1308522744, REVEL 0.04, MetaLR 0.08
- G48W (p.Gly48Trp), Ensembl rs2014182570, REVEL 0.35, MetaLR 0.23
- S50R (p.Ser50Arg), cosmic curated COSV54748, TOPMed rs1052011598, gnomAD rs1052011598, REVEL 0.04, MetaLR 0.04
- G52D (p.Gly52Asp), cosmic curated COSV10454, gnomAD rs1375360299, REVEL 0.02, MetaLR 0.05
- G54R (p.Gly54Arg), TOPMed rs1409252965, gnomAD rs1409252965, REVEL 0.15, MetaLR 0.11
- R55P (p.Arg55Pro), TOPMed rs1475971879, gnomAD rs1475971879, REVEL 0.17, MetaLR 0.09
- A56E (p.Ala56Glu), TOPMed rs1163524680, gnomAD rs1163524680, REVEL 0.05, MetaLR 0.03
- A57G (p.Ala57Gly), TOPMed rs2014181360
- A57S (p.Ala57Ser), gnomAD rs1433393602, REVEL 0.09, MetaLR 0.06
- G58D (p.Gly58Asp), TOPMed rs1055614214, REVEL 0.01, MetaLR 0.05
- R59K (p.Arg59Lys), TOPMed rs2014180886, REVEL 0.10, MetaLR 0.10
- R60L (p.Arg60Leu), rs2014180762, ClinGen CA396465877, ClinVar RCV004472035, TOPMed rs2014180762, REVEL 0.13, MetaLR 0.06, Uncertain significance, not specified
- A61P (p.Ala61Pro), NCI-TCGA TCGA novel, REVEL 0.04, MetaLR 0.05, Variant assessed as somatic; moderate impact.
- R63G (p.Arg63Gly), Ensembl rs2014180654, REVEL 0.07, MetaLR 0.07
- R63H (p.Arg63His), TOPMed rs1410828727, gnomAD rs1410828727, REVEL 0.05, MetaLR 0.07
- R63L (p.Arg63Leu), TOPMed rs1410828727, gnomAD rs1410828727, REVEL 0.14, MetaLR 0.07
- S64N (p.Ser64Asn), TOPMed rs1410466012, REVEL 0.02, MetaLR 0.04
- G66R (p.Gly66Arg), TOPMed rs2014180024, REVEL 0.35, MetaLR 0.16
- R67G (p.Arg67Gly), NCI-TCGA TCGA novel, REVEL 0.09, MetaLR 0.05, Variant assessed as somatic; high impact.
- R67W (p.Arg67Trp), gnomAD rs1181871917, REVEL 0.12, MetaLR 0.07
- A68G (p.Ala68Gly), TOPMed rs1471791865, gnomAD rs1471791865, REVEL 0.06, MetaLR 0.06, Uncertain significance
- A68V (p.Ala68Val), rs1471791865, ClinGen CA396465794, ClinVar RCV004076196, TOPMed rs1471791865, REVEL 0.10, MetaLR 0.06, Uncertain significance, not specified
- R69G (p.Arg69Gly), TOPMed rs909960303, REVEL 0.18, MetaLR 0.19
- R69W (p.Arg69Trp), TOPMed rs909960303, REVEL 0.18, MetaLR 0.19
- R70L (p.Arg70Leu), Ensembl rs968989144, REVEL 0.17, MetaLR 0.23
- R70W (p.Arg70Trp), gnomAD rs2014179341, REVEL 0.20, MetaLR 0.24
- G71E (p.Gly71Glu), rs1024858404, ClinGen CA283333294, ClinVar RCV004472036, TOPMed rs1024858404, REVEL 0.29, MetaLR 0.20, Uncertain significance, not specified
- R72L (p.Arg72Leu), gnomAD rs1196829935, REVEL 0.07, MetaLR 0.05
- H73Y (p.His73Tyr), rs368708983, gnomAD 16-69356985-G-A, CADD 12.40
- E74Q (p.Glu74Gln), Ensembl rs1013429019
- P75L (p.Pro75Leu), TOPMed rs1208445050, REVEL 0.05, MetaLR 0.05, Uncertain significance, not specified
- P75Q (p.Pro75Gln), TOPMed rs1208445050, REVEL 0.05, MetaLR 0.05, Uncertain significance
- G76R (p.Gly76Arg), gnomAD rs1324514163, REVEL 0.05, MetaLR 0.03
- G76V (p.Gly76Val), TOPMed rs1277309168, REVEL 0.06, MetaLR 0.07
- L77P (p.Leu77Pro), TOPMed rs1483680905, REVEL 0.10, MetaLR 0.13
- G78R (p.Gly78Arg), TOPMed rs2014177647, gnomAD rs2014177647, REVEL 0.06, MetaLR 0.07
- G79A (p.Gly79Ala), TOPMed rs2014177100, gnomAD rs2014177100
- G79C (p.Gly79Cys), ExAC rs748452006, TOPMed rs748452006, gnomAD rs748452006, REVEL 0.08, MetaLR 0.07
- G79D (p.Gly79Asp), TOPMed rs2014177100, gnomAD rs2014177100, REVEL 0.05, MetaLR 0.05
- G79V (p.Gly79Val), TOPMed rs2014177100, gnomAD rs2014177100, REVEL 0.05, MetaLR 0.09
- P80L (p.Pro80Leu), gnomAD rs1352033745, REVEL 0.04, MetaLR 0.06
- P80Q (p.Pro80Gln), gnomAD rs1352033745, REVEL 0.03, MetaLR 0.06
- A81G (p.Ala81Gly), 1000Genomes rs779098904, ExAC rs779098904, TOPMed rs779098904, gnomAD rs779098904, REVEL 0.08, MetaLR 0.05
- A81V (p.Ala81Val), 1000Genomes rs779098904, ExAC rs779098904, TOPMed rs779098904, gnomAD rs779098904, REVEL 0.06, MetaLR 0.04
- E82D (p.Glu82Asp), TOPMed rs1352640391, gnomAD rs1352640391, REVEL 0.05, MetaLR 0.04
- R83P (p.Arg83Pro), ExAC rs755403125, gnomAD rs755403125, REVEL 0.04, MetaLR 0.07
- A85S (p.Ala85Ser), TOPMed rs1304054862, gnomAD rs1304054862, REVEL 0.02, MetaLR 0.04
- G86R (p.Gly86Arg), ExAC rs754332485, gnomAD rs754332485, REVEL 0.12, MetaLR 0.12
- E87D (p.Glu87Asp), gnomAD rs2014175601, REVEL 0.06, MetaLR 0.05
- A88G (p.Ala88Gly), ESP rs146506589, ExAC rs146506589, TOPMed rs146506589, gnomAD rs146506589, REVEL 0.08, MetaLR 0.06, Uncertain significance
- A88V (p.Ala88Val), rs146506589, ClinGen CA283333262, ClinVar RCV004472034, ESP rs146506589, REVEL 0.03, MetaLR 0.06, Uncertain significance, not specified
- R89W (p.Arg89Trp), gnomAD rs1458501612, REVEL 0.16, MetaLR 0.12
- E92* (p.Glu92Ter), gnomAD rs1423732116, CADD 36.00
- A93V (p.Ala93Val), cosmic curated COSV54748, ExAC rs767090688, TOPMed rs767090688, gnomAD rs767090688, REVEL 0.06, MetaLR 0.07
- N95D (p.Asn95Asp), cosmic curated COSV10583, ExAC rs774078692, gnomAD rs774078692, REVEL 0.09, MetaLR 0.26
- N95S (p.Asn95Ser), ExAC rs763759558, TOPMed rs763759558, gnomAD rs763759558, REVEL 0.26, MetaLR 0.25
- R96L (p.Arg96Leu), ExAC rs762744055, TOPMed rs762744055, gnomAD rs762744055, REVEL 0.55, MetaLR 0.25, Uncertain significance, not specified
- R96P (p.Arg96Pro), ExAC rs762744055, TOPMed rs762744055, gnomAD rs762744055, REVEL 0.54, MetaLR 0.25
- W97R (p.Trp97Arg), Ensembl rs2014173607
- V98L (p.Val98Leu), ExAC rs775350860, gnomAD rs775350860, REVEL 0.12, MetaLR 0.25
- A106E (p.Ala106Glu), ExAC rs773142757
- R108Q (p.Arg108Gln), ExAC rs772214740, TOPMed rs772214740, gnomAD rs772214740, REVEL 0.13, MetaLR 0.12
- R108W (p.Arg108Trp), gnomAD rs1314724446
- A109V (p.Ala109Val), ExAC rs748277244, gnomAD rs748277244, REVEL 0.15, MetaLR 0.28
- R111G (p.Arg111Gly), NCI-TCGA Cosmic COSV5474, cosmic curated COSV54748, Variant assessed as somatic; moderate impact.
- R111W (p.Arg111Trp), NCI-TCGA Cosmic COSV5474, Variant assessed as somatic; moderate impact.
- G112C (p.Gly112Cys), NCI-TCGA Cosmic COSV9965, cosmic curated COSV99651, Variant assessed as somatic; moderate impact.
- G112D (p.Gly112Asp), ExAC rs779198488, gnomAD rs779198488, REVEL 0.08, AlphaMissense 0.15, Uncertain significance, not specified
- G112V (p.Gly112Val), rs779198488, ExAC rs779198488, gnomAD rs779198488, REVEL 0.10, AlphaMissense 0.07, Uncertain significance
- S113G (p.Ser113Gly), Ensembl rs2014171859, REVEL 0.14, MetaLR 0.03
- G116E (p.Gly116Glu), rs749653608, ClinGen CA8135001, ClinVar RCV004312643, ExAC rs749653608, REVEL 0.10, MetaLR 0.05, Uncertain significance, not specified
- G116R (p.Gly116Arg), gnomAD rs1389007118, REVEL 0.04, AlphaMissense 0.08, Uncertain significance, not specified
- D117N (p.Asp117Asn), rs774078692, []
- Q120E (p.Gln120Glu), gnomAD rs1367106356, REVEL 0.10, AlphaMissense 0.07
- Q120H (p.Gln120His), ExAC rs756653255, gnomAD rs756653255
- I121V (p.Ile121Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R122Q (p.Arg122Gln), gnomAD rs1247479774, REVEL 0.19, MetaLR 0.25
- M125L (p.Met125Leu), Ensembl rs2014170648, REVEL 0.24, AlphaMissense 0.09
- M125V (p.Met125Val), Ensembl rs2014170648, REVEL 0.38, AlphaMissense 0.06
- Q126E (p.Gln126Glu), ExAC rs766892852, gnomAD rs766892852, REVEL 0.14, MetaLR 0.16
- Q126L (p.Gln126Leu), gnomAD rs1466400497, REVEL 0.26, MetaLR 0.24
- Q126R (p.Gln126Arg), gnomAD rs1466400497, REVEL 0.16, MetaLR 0.24
- A127V (p.Ala127Val), Ensembl rs1567458355, REVEL 0.13, MetaLR 0.09
- R131K (p.Arg131Lys), Ensembl rs2142778635
- G134R (p.Gly134Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E136D (p.Glu136Asp), gnomAD rs2014159587, REVEL 0.01, MetaLR 0.05
- H137Q (p.His137Gln), ExAC rs781470092, TOPMed rs781470092, gnomAD rs781470092, REVEL 0.24, MetaLR 0.03
- H137Y (p.His137Tyr), gnomAD rs1336939532, REVEL 0.14, MetaLR 0.05
- T138A (p.Thr138Ala), gnomAD rs2014159179, REVEL 0.08, MetaLR 0.03
- T138S (p.Thr138Ser), gnomAD rs1412885922, REVEL 0.04, AlphaMissense 0.82
- V139M (p.Val139Met), ExAC rs747511003, TOPMed rs747511003, gnomAD rs747511003, REVEL 0.05, AlphaMissense 0.19
- S140F (p.Ser140Phe), TOPMed rs937154078, gnomAD rs937154078, REVEL 0.14, MetaLR 0.11
- S140P (p.Ser140Pro), Ensembl rs2142778461
- V145I (p.Val145Ile), TOPMed rs1236887794, gnomAD rs1236887794, REVEL 0.06, MetaLR 0.05, Uncertain significance, not specified
- C148W (p.Cys148Trp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S150P (p.Ser150Pro), NCI-TCGA Cosmic COSV5474, cosmic curated COSV54749, Variant assessed as somatic; moderate impact.
- S150V (p.Ser150Val), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
Public TERF2 analysis runs
- TERF2 analysis run — TERF2 (753 variants) — completed 2026-08-20